Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Champions Oncology, Inc. - Common Stock (NQ:CSBR)

5.080 +0.130 (+2.63%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 28,881
Open 4.990
Bid (Size) 4.820 (100)
Ask (Size) 5.120 (200)
Prev. Close 4.950
Today's Range 4.870 - 5.200
52wk Range 4.590 - 8.310
Shares Outstanding 13,415,066
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Champions Oncology (CSBR) Q1 2027 Earnings Call Transcript ↗
Data licensing revenue surged past full-year fiscal 2026 totals in single quarter. 
Via The Motley Fool
Topics Earnings
News headline image
Champions Oncology Q1 Earnings Call Highlights ↗
Champions Oncology (NASDAQ:CSBR) reported first-quarter fiscal 2027 revenue growth, improved margins and its fifth consecutive quarter of positive adjusted EBITDA, as both its translational oncology... 
Via MarketBeat
Topics Earnings

Performance

YTD
-23.7%
-23.7%
1 Month
-0.2%
-0.2%
3 Month
-19.6%
-19.6%
6 Month
-18.1%
-18.1%
1 Year
-20.0%
-20.0%

More News

Read More
Champions Oncology (NASDAQ:CSBR) Shares Jump as Q1 Margins Expand and Adjusted EBITDA Turns Higher ↗
Via Chartmill
News headline image
Champions Oncology Reports Revenue of $15.2 Million
From Champions Oncology, Inc.
Via ACCESS Newswire
Champions Oncology (NASDAQ:CSBR) Surges on Earnings Beat and Margin Expansion, Highlighting Quality Growth Stock ↗
Via Chartmill
Topics Earnings
Champions Oncology Inc. (NASDAQ:CSBR) Shares Surge on Record Study Revenue Despite Q3 Earnings Miss ↗
Via Chartmill
News headline image
Champions Oncology to Announce First Quarter Financial Results on Thursday, September 10, 2026
From Champions Oncology, Inc.
Via ACCESS Newswire
News headline image
Champions Oncology Expands Integrated Radiopharmaceutical Development Platform with In-House SPECT/CT Imaging
From Champions Oncology, Inc.
Via ACCESS Newswire
News headline image
Champions Oncology Q4 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
Champions Oncology Reports Record Annual Revenue of $59 Million
From Champions Oncology, Inc.
Via ACCESS Newswire
News headline image
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 27, 2026
From Champions Oncology, Inc.
Via ACCESS Newswire
News headline image
Champions Oncology to Present New Data on Predicting Response and Resistance at AACR 2026
Via ACCESS Newswire
News headline image
Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy
Via ACCESS Newswire
News headline image
Champions Oncology (CSBR) Earnings Transcript ↗
Via The Motley Fool
News headline image
Champions Oncology Reports Revenue of $16.6 Million
Via ACCESS Newswire
News headline image
Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2026
Via ACCESS Newswire
News headline image
Fund Discloses $25 Million Braze Stock Investment Amid 60% Share Plunge ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Battery Management Dumps $9 Million Zeta Stake as Shares Slide 38% Year Over Year ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Battery Takes $124 Million Bet on Kodiak AI. Here's What Investors Should Know ↗
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Sprinklr Stock Down 40% in a Year as One Fund Sells Nearly $3 Million Worth of Shares ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Champions Oncology (CSBR) Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Champions Oncology (CSBR) Earnings Transcript ↗
Via The Motley Fool
News headline image
Champions Oncology Inc (NASDAQ:CSBR) Beats Revenue Estimates and Returns to Profitability in Q2 ↗
Via Chartmill
News headline image
Champions Oncology Reports Record Quarterly Service Revenue of $14.9 Million
Via ACCESS Newswire
News headline image
CORRECTION: Champions Oncology Reports Quarterly Revenue of $14.0 Million
Via ACCESS Newswire

Frequently Asked Questions

Is Champions Oncology, Inc. - Common Stock publicly traded?
Yes, Champions Oncology, Inc. - Common Stock is publicly traded.
What exchange does Champions Oncology, Inc. - Common Stock trade on?
Champions Oncology, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Champions Oncology, Inc. - Common Stock?
The ticker symbol for Champions Oncology, Inc. - Common Stock is CSBR on the Nasdaq Stock Market
What is the current price of Champions Oncology, Inc. - Common Stock?
The current price of Champions Oncology, Inc. - Common Stock is 5.080
When was Champions Oncology, Inc. - Common Stock last traded?
The last trade of Champions Oncology, Inc. - Common Stock was at 09/17/26 04:00 PM ET
What is the market capitalization of Champions Oncology, Inc. - Common Stock?
The market capitalization of Champions Oncology, Inc. - Common Stock is 68.15M
How many shares of Champions Oncology, Inc. - Common Stock are outstanding?
Champions Oncology, Inc. - Common Stock has 68M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.